Regional chemotherapy and transcatheter arterial chemoembolization

Digestion

Volumn 59, Issue SUPPL. 2, 1998, Pages 83-85

  Gallkowski, U ^a   Low, A ^a   Hirner, A ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Liver cirrhosis; Regional chemotherapy

Indexed keywords

AFLATOXIN; DOXORUBICIN; DRUG CARRIER; IODINATED POPPYSEED OIL;

ANOREXIA; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER SURVIVAL; CONFERENCE PAPER; DRUG HALF LIFE; FEVER; HEPATITIS B; HEPATITIS C; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; LIVER NEOPLASMS;

EID: 0031873891     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051433     Document Type: Conference Paper

References (15)

1. Carr BI, Flickinger JC, Lotze MT: Hepatobiliary cancers; in DeVita VT, Hellmann S, Rosenberg SA (eds): Cancer. Principles and Practice of Oncology. Philadelphia, Lippincott-Raven, 1997, p 1087.
2. Bassermann R: Angiogenese und Vaskularisation in Metastasen. Verh Dtsch Ges Pathol 1984;68:124-139.
3. Ensminger WD, Gyves JW: Regional cancer chemotherapy. Cancer Treat Rep 1984;68:101-115.
4. Kanematsu T, Matsumata T, Furuta T, Shirabe K., Yamagata M, Utsunomiya T, Sugimachi A: Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma. Hepatogastroenterology 1990;37:442-444.
5. Raoul JI, Heresbach D, Bretagne JF, Ferrer DB, Duvauferrier R, Bourgue P, Messner M, Gosselin M: Chemoembolization of hepatocellular carcinoma. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 1992; 70:585-590.
6. Collins J: Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984;2:498-504.
7. Hyo-Suk L, Joo Sung K, Il Ju C, Jin Wook C, Jae Hyung P, Chung Yong K: The safely and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepato-cellular carcinoma and main portal vein obstruction. Cancer 1997;79:2087-2094.
8. Vetter D, Wenger J-J, Bergier JM, Doffoel M, Bockel R: Transcatheter oily chemoembolization in the management of advanced hepato-cellular carcinoma in cirrhosis: Results of a Western comparative study in 60 patients. Hepatology 1991;13:427-433.
9. Bismuth H, Morino M, Sherlock D, Castaing D. Miglietta C, Cauquil P, Roche A: Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992;163: 387-394.
10. Bruix J, Bru C: Medical treatment of hepato-cellular carcinoma; in Rodes J, Arroyo V (eds): Therapy in Liver Diseases. Barcelona, Ediciones Doyma, 1992, pp 427-437.
11. Galanski M, Schmoll E, Reichelt S, Bohmer G, Prokop M, Schaefer C, Schuler A, Ringe B, Schmidt FW, Schmoll HJ: Chemoembolisation hepatozellulärer Karzinome bei isoliertem Leberbefall. Radiologe 1992;32:49-55.
12. Ikeda K, Kumada H, Satoh S, Arase Y, Chayama K: Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991;68: 2150-2154.
13. Stefanini GF, Amorati P, Biselli M, Mucci F, Celi A, Arienti V, Roversi R, Rossi C, Re G, Gasbarrini G: Efficacy of transarterial targeted treatments on survival of patients with hepato-cellular carcinoma. An Italian experience. Cancer 1995;75:2427-2434.
14. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire: A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-1261.
15. Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, Deugnier YM, Gosselin M: Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: Intra-arterial iodine-131 iodized oil versus medical support. J Nucl Med 1994;35: 1782-1787.